SynthesisFrontiers in oncology2019

Prognostic Roles of Blood Inflammatory Markers in Hepatocellular Carcinoma Patients Taking Sorafenib. A Systematic Review and Meta-Analysis.

Lixing Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.